Detection of malignant melanoma in a giant congenital naevocytic naevus by positron emission tomography [14]

British Journal of Dermatology

Volumn 151, Issue 3, 2004, Pages 724-726

  Makosz, T ^a   Assaf, C ^a   Georgieva, J ^a   Orfanos, C E ^a   Geilen, C C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE; MELAN A; PROTEIN S 100;

ADULT; CANCER INVASION; CANCER RISK; CANCER STAGING; CASE REPORT; CELLULAR DISTRIBUTION; CONGENITAL NEVUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; MELANOMA; NEVUS CELL; PATIENT MONITORING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; TUMOR BIOPSY; TUMOR LOCALIZATION;

HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NEVUS, PIGMENTED; POSITRON-EMISSION TOMOGRAPHY; SKIN NEOPLASMS;

EID: 4944227260     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06162.x     Document Type: Letter

References (10)

1. DeDavid M, Orlow SJ, Provost M et al. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. J Am Acad Dermatol 1997; 36: 409-16.
2. Rompel R, Moser M, Petres J. Dermabrasion of congenital nevocellular nevi: experience in 215 patients. Dermatology 1997; 194: 261-7.
3. Fishman C, Mihm MC Jr, Sober AJ. Diagnosis and management of nevi and cutaneous melanoma in infants and children. Clin Dermatol 2002; 20: 44-50.
4. Bittencourt FV, Marghoob AA, Kopf AW et al. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis. Pediatrics 2000; 106: 736-41.
5. Egan CL, Oliveria SA, Elenitsas R et al. Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. J Am Acad Dermatol 1998; 39: 923-32.
6. Kopf AW, Bart RS, Hennessey P. Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1979; 1: 123-30.
7. Longo MI, Lazaro P, Bueno C et al. Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients. Dermatol Surg 2003; 29: 245-8.
8. Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001; 2: 157-64.
9. Wagner JD, Schauwecker D, Hutchins G, Coleman JJ III. Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma. J Surg Oncol 1997; 64: 181-9.
10. Macfarlane DJ, Sondak V, Johnson T, Wahl RL. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma. J Clin Oncol 1998; 16: 1770-6.